Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial

This study aims to explore a promising new surgical approach for managing NVG and contribute to the advancement of glaucoma treatment strategies.Trial registrationChiCTR ChiCTR2200055138. Registered on 01 January 2022. https://www.chictr.org.cn/showproj.html?proj=145255.

http://link.springer.com/10.1186/s13063-024-08123-8

Source: Trials - April 29, 2024 Category: Research Source Type: clinical trials

More News: Glaucoma | Research | Study